Clinical trial
Functional Brain Imaging and Employment in First-Episode Psychotic Patients…
NCT00314613 · Duke University, Other · Terminated
Key facts
| NCT number | NCT00314613 |
|---|---|
| Title | Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal |
| Official title | Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal |
| Lead sponsor | Duke University, Other |
| Collaborators | Janssen, LP Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Antipsychotic/Risperidone Consta |
| Enrollment | 30 |
| Start date | Apr 1, 2006 |
| Primary completion | Dec 1, 2006 |
| First posted | Apr 14, 2006 |
| Last update posted | Dec 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: